251 – 260 of 354
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
Free-to-total prostate-specific antigen ratio as a predictor of non-organ-confined prostate cancer (stage pT3)
(
- Contribution to journal › Article
-
Mark
Expression and immunolocalisation of neutral endopeptidase in prostate cancer
(
- Contribution to journal › Article
-
Mark
Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen
(
- Contribution to journal › Article
-
Mark
Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Sweden
(
- Contribution to journal › Article
-
Mark
Expression of protein C inhibitor (PCI) in benign and malignant prostatic tissues
(
- Contribution to journal › Article
- 2002
-
Mark
Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.
(
- Contribution to journal › Article
-
Mark
Simultaneous quantification of prostate-specific antigen and human glandular kallikrein 2 mRNA in blood samples from patients with prostate cancer and benign disease
(
- Contribution to journal › Article
-
Mark
Measurement of the noncomplexed free fraction of tissue inhibitor of metalloproteinases I in plasma by immunoassay
(
- Contribution to journal › Article
-
Mark
Prediction of tumor heterogeneity in localized prostate cancer
(
- Contribution to journal › Article
-
Mark
Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer
(
- Contribution to journal › Article